 |
Legendary
|
|
Join Date: Sep 2006
Posts: 18,914
|
|
|
Legendary
Join Date: Sep 2006
Posts: 18,914
|
Open Clinical Trials: Bipolar Disorder
Open trials from the Depression and Bipolar Support Website:
http://www.dbsalliance.org/site/Page...ls_bipolarlist
I cut and pasted a few of them here.
Go to the web site if you want to know about more studies or for contact information.
Quote:
Bipolar Study - Rockville, MD
Description: We are conducting an investigational research study for Bipolar Disorder and you may qualify. This study will evaluate the safety and effectiveness of an investigational medication in treating Bipolar Disorder. All study related care is provided to qualified participants at no charge, including physical and psychiatric assessments, laboratory services and study medication. Compensation is provided for time and travel.
|
Quote:
Collaborative Lithium Trial
Description: This is a multiphase, multicenter, trial that will closely look at lithium for the treatment of child and adolescent subjects between the ages of 7-17 with bipolar I disorder. Symptoms of pediatric bipolar disorder may include extreme mood swings, intense irritability, sadness, and silliness. Often, children with bipolar disorder have difficulty sleeping and at times may engage in risky behavior. These symptoms can affect day to day life. In order to look at the treatment of bipolar disorder with lithium, this study will include four phases of treatment.
The first phase, called the Pharmacokinetic Phase, will include 8 weeks of Open Label treatment to determine guidelines for the amount of lithium that is best for children and adolescents with bipolar disorder. Subjects completing the Pharmacokinetic Phase, may be eligible to continue in the Long-Term Effectiveness Phase for a maximum of 16 weeks of lithium treatment. Afterward, subjects may be eligible to continue in the Discontinuation Phase. During the Discontinuation Phase, subjects will be selected to either placebo (a sugar pill) or lithium for up to 28 weeks. Finally, subjects whose symptoms return during the Discontinuation Phase may be asked to be enrolled in an Open Label Restabilization Phase and treated with lithium for up to 8 weeks.
|
Quote:
Genomic Study of Bipolar Disorder
Description: If you have bipolar disorder, you may qualify to particpate. Participation in the studies involve having an interview with a clinician and having a small blood sample taken. Some individuals will be eligible to participate in additional research studies. During your participation in the study, all information gathered will be confidential and resulst will be published in a manner to ensure anonymity.
|
Quote:
Taurine as an Anti-Manic Agent
Description: This study is for adolescents (aged 13-18) with bipolar disorder. It involves the use of taurine, an amino acid that is often used as a dietary supplement. This three month clinical study gives the volunteer a thorough psychological and physical evaluation. In addition, the child and family will keep a daily mood diary to monitor the effectiveness and any side effects of taurine. Participants will be able to remain on their current medications.
This study also includes an optional neuroimaging component. Interested participants will receive a clinical brain scan and 4 research scans to look at chemicals in the brain.
|
Quote:
Lithium for Treatment of Pediatric Mania
Description: This multiphase, multi-site study is funded by the federal government in order to provide healthy and safety information about the use of a mood stabilizer in children. The study will include four phases of treatment. The first phase will include 8 weeks of open-label treatment to determine dosing strategies for children and adolescents with bipolar disorder.
Once patients complete this phase, they may be eligible to continue in the Long-Term Effectiveness Phase for up to 16 weeks of lithium treatment. Patients meeting response criteria during the Long-Term Effectiveness Phase will be eligible to continue in the Discontinuation Phase. During the Discontinuation Phase, subjects will be randomized to either placebo or mood stabilizer treatment for up to 28 weeks.
Finally, those subjects who experience a mood relapse during the Discontinuation Phase can reinitiate mood stabilizer treatment for up to 8 weeks in an open-label Restabilization Phase. All treatment is free of charge. Patients are closely monitored by a team of child psychiatrists, psychologists, and clinical nurse specialists throughout their treatment.
|
Quote:
Pediatric Bipolar Disorder
Description: This year long study will evaluate the effects of a mood stabilizer in children ages 7-17 with bipolar disorder. There are four phases of the study and participants are eligible to continue into the next phase after completing the preceding phases. Participants will receive thorough psychiatric and physical evaluations throughout the study. All care is free of charge.
|
Quote:
Mixed Bipolar Disorder Trial
Description: Mixed Bipolar is a disorder that can cause people to experience both manic and depressive symptoms at the same time. Manic symptoms can include: distractibility, racing thoughts, decreased need for sleep, restlessness. Depressive symptoms can include: feeling sad,losing interest in your day to day activities, sleeplessness, inability to concentrate, lack of energy. If you checked YES to 3 or more symptoms in each category, you may qualify to participate in a research study and possibly receive the following at no charge: professional medical examinations, study drug, lab results and other information about your health.
Qualified participants may be compensated up to $450.
|
Quote:
Reproductive Function & Mood in Women w/Bipolar Disorder
Description: Women with BIPOLAR DISORDER needed for study on REPRODUCTIVE FUNCTION AND MOOD. The Stanford Department of Psychiatry and Behavioral Sciences is seeking women who are currently treated for bipolar disorder for a study on mood, hormones, and the menstrual cycle. Participants are will receive up to $175 reimbursement and a careful evaluation of their reproductive function. If you are a woman between the ages of 18 and 45, are currently treated for bipolar disorder, and are not on oral contraceptives, you may be eligible to participate.
|
|